Citation Impact
Citing Papers
Sulfur [ 18 F]Fluoride Exchange Click Chemistry Enabled Ultrafast Late-Stage Radiosynthesis
2021 StandoutNobel
1 Developmental roles and clinical significance of Hedgehog signaling
2003
Molecular imaging of hypoxia with radiolabelled agents
2009
The putative tumor suppressors EXT1 and EXT2 form a stable complex that accumulates in the Golgi apparatus and catalyzes the synthesis of heparan sulfate
2000
Heparan sulfate proteoglycans and cancer
2001
A Visualizable Chain‐Terminating Inhibitor of Glycosaminoglycan Biosynthesis in Developing Zebrafish
2014 StandoutNobel
Artificially engineered magnetic nanoparticles for ultra-sensitive molecular imaging
2006 Standout
Heparin-Protein Interactions
2002 Standout
Why do cancers have high aerobic glycolysis?
2004 Standout
Molecular imaging in drug development
2008 Standout
Hedgehog: functions and mechanisms
2008 Standout
Targeting hypoxia in cancer therapy
2011 Standout
OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines
2008 Standout
Cu–ATSM: A radiopharmaceutical for the PET imaging of hypoxia
2007
Quantitative multimodality imaging in cancer research and therapy
2014
The Stem Region of the Sulfotransferase GlcNAc6ST-1 Is a Determinant of Substrate Specificity
2004 StandoutNobel
The Future of Cancer Imaging
2002
Hedgehog Movement Is Regulated through tout velu–Dependent Synthesis of a Heparan Sulfate Proteoglycan
1999
Cerebral microbleeds: a guide to detection and interpretation
2009 Standout
Hereditary multiple exostoses and heparan sulfate polymerization
2002
18FDG-Positron emission tomography for the early prediction of response in advanced soft tissue sarcoma treated with imatinib mesylate (Glivec®)
2003
Comparison of the pharmacokinetics of 68Ga-DOTATOC and [18F]FDG in patients with metastatic neuroendocrine tumours scheduled for 90Y-DOTATOC therapy
2006
Functional imaging of intratumoral hypoxia
2004
Skeletal PET with18F-Fluoride: Applying New Technology to an Old Tracer
2007
Nomograms in oncology: more than meets the eye
2015 Standout
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
2008 Standout
Incidence of Sarcoma Histotypes and Molecular Subtypes in a Prospective Epidemiological Study with Central Pathology Review and Molecular Testing
2011 Standout
Gold Nanocages: A Novel Class of Multifunctional Nanomaterials for Theranostic Applications
2010
Targeting gold nanocages to cancer cells for photothermal destruction and drug delivery
2010
Sarcoma: concordance between initial diagnosis and centralized expert review in a population-based study within three European regions
2012
Autoradiographic and small-animal PET comparisons between 18F-FMISO, 18F-FDG, 18F-FLT and the hypoxic selective 64Cu-ATSM in a rodent model of cancer
2008
Soft-Tissue Sarcomas in Adults
2005 Standout
EVALUATION OF THE FOREARM IN UNTREATED ADULT SUBJECTS WITH MULTIPLE HEREDITARY OSTEOCHONDROMATOSIS
2002
The new bone biology: Pathologic, molecular, and clinical correlates
2006
The roles of enzyme localisation and complex formation in glycan assembly within the Golgi apparatus
2004 StandoutNobel
Targeting the Hedgehog pathway in cancer
2006 Standout
Machine Learning methods for Quantitative Radiomic Biomarkers
2015 Standout
From Krebs to clinic: glutamine metabolism to cancer therapy
2016 Standout
Examining the relationship between Cu-ATSM hypoxia selectivity and fatty acid synthase expression in human prostate cancer cell lines
2008
Synthesis of Prussian Blue Nanoparticles with a Hollow Interior by Controlled Chemical Etching
2011 StandoutNobel
The golden age: gold nanoparticles for biomedicine
2011 Standout
Regulation of cancer cell metabolism
2011 Standout
Gold Nanocages as Photothermal Transducers for Cancer Treatment
2010
The EXT2 multiple exostoses gene defines a family of putative tumour suppressor genes
1996
Fast spin-echo MR imaging of the brain and spine: current concepts.
1992
Unraveling the therapeutic potential of the Hedgehog pathway in cancer
2013 Standout
Partners in transcription: NFAT and AP-1
2001 Standout
Quantification of Heterogeneity as a Biomarker in Tumor Imaging: A Systematic Review
2014
Tumor Treatment Response Based on Visual and Quantitative Changes in Global Tumor Glycolysis Using PET-FDG Imaging The Visual Response Score and the Change in Total Lesion Glycolysis
1999
Hypoxia: Importance in tumor biology, noninvasive measurement by imaging, and value of its measurement in the management of cancer therapy
2006
Hedgehog signaling in animal development: paradigms and principles
2001 Standout
GlcNAc 2-Epimerase Can Serve a Catabolic Role in Sialic Acid Metabolism
2003 StandoutNobel
ARTHRODESIS OF THE KNEE
2004
Genome-Scale Identification of SARS-CoV-2 and Pan-coronavirus Host Factor Networks
2020 StandoutNobel
The putative tumour suppressor EXT1 alters the expression of cell-surface heparan sulfate
1998
Mutation screening of EXT1 and EXT2 by direct sequence analysis and MLPA in patients with multiple osteochondromas: splice site mutations and exonic deletions account for more than half of the mutations
2004
The many roles of histone deacetylases in development and physiology: implications for disease and therapy
2008 Standout
Golgi Localization of Carbohydrate Sulfotransferases Is a Determinant of L-selectin Ligand Biosynthesis
2003 StandoutNobel
A Pragmatic Guide to Enrichment Strategies for Mass Spectrometry–Based Glycoproteomics
2020 StandoutNobel
Using Positron Emission Tomography with [18F]FDG to Predict Tumor Behavior in Experimental Colorectal Cancer
2001
Epidemiological evaluation of concordance between initial diagnosis and central pathology review in a comprehensive and prospective series of sarcoma patients in the Rhone-Alpes region
2010
Imaging hypoxia and angiogenesis in tumors
2005
The Putative Tumor Suppressors EXT1 and EXT2 Are Glycosyltransferases Required for the Biosynthesis of Heparan Sulfate
1998
From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors
2009 Standout
Overview of early response assessment in lymphoma with FDG-PET
2007
Gold nanoparticles in biomedical applications: recent advances and perspectives
2011 Standout
Artificial intelligence in radiology
2018 Standout
Hedgehog Signaling in Development and Cancer
2008 Standout
RECIST revisited: A review of validation studies on tumour assessment
2006
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
2014 Standout
Evidence for an Expansion-Based Temporal Shh Gradient in Specifying Vertebrate Digit Identities
2004 Standout
Golgi Glycosylation and Human Inherited Diseases
2011
The value of FDG-PET in the detection, grading and response to therapy of soft tissue and bone sarcomas; a systematic review and meta-analysis
2003
Drug Resistance and the Solid Tumor Microenvironment
2007 Standout
Methods for Noninvasive Imaging of Tissue Hypoxia
2007
Glycosaminoglycans and their proteoglycans: host‐associated molecular patterns for initiation and modulation of inflammation
2006 Standout
Chemical Design and Synthesis of Functionalized Probes for Imaging and Treating Tumor Hypoxia
2017
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
2010 Standout
Nanoparticles for photothermal therapies
2014 Standout
Gene Regulatory Networks and the Evolution of Animal Body Plans
2006 StandoutScience
SQV-7, a protein involved in Caenorhabditis elegans epithelial invagination and early embryogenesis, transports UDP-glucuronic acid, UDP- N - acetylgalactosamine, and UDP-galactose
2001 StandoutNobel
Positron Emission Tomography As an Imaging Biomarker
2006
Molecular Genetics and Cytogenetics of Sarcomas
1995
Fluorescence Lifetime Measurements and Biological Imaging
2010 Standout
Functional Nanomaterials for Phototherapies of Cancer
2014 Standout
[18F]Fluorodeoxyglucose Positron Emission Tomography Predicts Outcome for Ewing Sarcoma Family of Tumors
2005
The Nuclear Factor of Activated T Cells (Nfat) Transcription Factor Nfatp (Nfatc2) Is a Repressor of Chondrogenesis
2000
25th Anniversary Article: Galvanic Replacement: A Simple and Versatile Route to Hollow Nanostructures with Tunable and Well‐Controlled Properties
2013 Standout
Whatʼs New in Pediatric Orthopaedics
2004 Standout
Controlling the Synthesis and Assembly of Silver Nanostructures for Plasmonic Applications
2011 Standout
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Progress and Promise of FDG-PET Imaging for Cancer Patient Management and Oncologic Drug Development
2005
Cocatalysts for Selective Photoreduction of CO2into Solar Fuels
2019 Standout
Developmental Pathways in Musculoskeletal Neoplasia: Involvement of the Indian Hedgehog-Parathyroid Hormone-Related Protein Pathway
2003
Functions of Cell Surface Heparan Sulfate Proteoglycans
1999 Standout
Hereditary multiple exostosis and chondrosarcoma: linkage to chromosome II and loss of heterozygosity for EXT-linked markers on chromosomes II and 8.
1995
Works of E U Conrad being referenced
[18F]FMISO and [18F]FDG PET imaging in soft tissue sarcomas: correlation of hypoxia, metabolism and VEGF expression
2003
Errors in Diagnosis and Margin Determination of Soft-Tissue Sarcomas Initially Treated at Non-Tertiary Centers
2004
Comparison of STIR and spin-echo MR imaging at 1.5 T in 45 suspected extremity tumors: lesion conspicuity and extent.
1991
FDG PET but not RECIST agrees with histologic response of soft tissue sarcoma to neoadjuvant chemotherapy
2005
A Statistical Modeling Approach to the Analysis of Spatial Patterns of FDG-PET Uptake in Human Sarcoma
2011
The natural history of hereditary multiple exostoses.
1994
Loss of heterozygosity in chondrosarcomas for markers linked to hereditary multiple exostoses loci on chromosomes 8 and 11.
1995
(F-18) fluorodeoxyglucose positron emission tomography as a predictor of pathologic grade and other prognostic variables in bone and soft tissue sarcoma.
2000
Contralateral total hip arthroplasty or ipsilateral total knee arthroplasty in patients who have a long-standing fusion of the hip.
1989
Quantitative [F-18]fluorodeoxyglucose positron emission tomography in pretreatment and grading of sarcoma.
1998